| Literature DB >> 17135396 |
Eduard Stefan1, Burkhard Wiesner, George S Baillie, Rustam Mollajew, Volker Henn, Dorothea Lorenz, Jens Furkert, Katja Santamaria, Pavel Nedvetsky, Christian Hundsrucker, Michael Beyermann, Eberhard Krause, Peter Pohl, Irene Gall, Andrew N MacIntyre, Sebastian Bachmann, Miles D Houslay, Walter Rosenthal, Enno Klussmann.
Abstract
The cAMP/protein kinase A (PKA)-dependent insertion of water channel aquaporin-2 (AQP2)-bearing vesicles into the plasma membrane in renal collecting duct principal cells (AQP2 shuttle) constitutes the molecular basis of arginine vasopressin (AVP)-regulated water reabsorption. cAMP/PKA signaling systems are compartmentalized by A kinase anchoring proteins (AKAP) that tether PKA to subcellular sites and by phosphodiesterases (PDE) that terminate PKA signaling through hydrolysis of localized cAMP. In primary cultured principal cells, AVP causes focal activation of PKA. PKA and cAMP-specific phosphodiesterase-4D (PDE4D) are located on AQP2-bearing vesicles. The selective PDE4 inhibitor rolipram increases AKAP-tethered PKA activity on AQP2-bearing vesicles and enhances the AQP2 shuttle and thereby the osmotic water permeability. AKAP18delta, which is located on AQP2-bearing vesicles, directly interacts with PDE4D and PKA. In response to AVP, PDE4D and AQP2 translocate to the plasma membrane. Here PDE4D is activated through PKA phosphorylation and reduces the osmotic water permeability. Taken together, a novel, compartmentalized, and physiologically relevant cAMP-dependent signal transduction module on AQP2-bearing vesicles, comprising anchored PDE4D, AKAP18delta, and PKA, has been identified.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17135396 DOI: 10.1681/ASN.2006020132
Source DB: PubMed Journal: J Am Soc Nephrol ISSN: 1046-6673 Impact factor: 10.121